Arkolith/Insider Trading/RVNC/Form 4

Sjuts Dustin S

PresidentRevance Therapeutics, Inc. (RVNC) · full profile →Form 4 · filed May 16, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$726K
Net Open-Market Flow
-$726K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2023Sell(S)21K$34.55$726K152K
Feb 2, 2022Grant(A)52K—$0173K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001479290-23-000073) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML